Company intelligence / Profile preview

IND Diagnostic

Delta, British Columbia, Canada

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

IND Diagnostic develops and manufactures a range of in-vitro diagnostic devices and rapid test kits for clinical use. Their products include FDA-cleared home-use multi-panel and single-drug urine immunoassays for drugs of abuse as well as urinalysis reagent strips and analyzers. The company also supplies diagnostic equipment for infectious diseases including HIV. Their products are available internationally with regulatory clearances such as FDA 510(k) for several devices.

Therapeutic areas: Metabolic DisordersPsychiatryInfectious Diseases
Modalities: DeviceImmunoassayIn-vitro diagnostic test
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on IND Diagnostic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IND Diagnostic.

Explore the full profile